Libros sobre el tema "Pharma marketing"

Harms, Fred, Dorothee Gänshirt y Robin Rumler, eds. Pharma-Marketing. Berlin, Boston: De Gruyter, 2008. http://dx.doi.org/10.1515/9783110504040.

Dichtl, Erwin, Hans Raffée y Michael Thiess, eds. Innovatives Pharma-Marketing. Wiesbaden: Gabler Verlag, 1989. http://dx.doi.org/10.1007/978-3-322-89322-2.

Umbach, Günter. Erfolgreich im Pharma-Marketing. Wiesbaden: Gabler, 2011. http://dx.doi.org/10.1007/978-3-8349-6559-2.

Umbach, Günter. Erfolgreich im Pharma-Marketing. Wiesbaden: Gabler Verlag, 2013. http://dx.doi.org/10.1007/978-3-8349-4571-6.

Umbach, Günter. Erfolgreich im Pharma-Marketing. Wiesbaden: Springer Fachmedien Wiesbaden, 2018. http://dx.doi.org/10.1007/978-3-658-18482-7.

Gehrig, Walter. Pharma-Marketing: Instrumente, Organisation und Methoden : national und international. Zürich: Verlag Moderne Industrie, 1987.

Walther, Hans-Peter. Erfolgreiches strategisches Pharma-Marketing: Eine theoriegeleitete empirische Studie auf der Grundlage des situativen Ansatzes. Frankfurt am Main: Lang, 1988.

Becker, Helmut E. Kommunikations-Strategien im Pharma-Markt: Verhaltenswissenschaftliche Ansätze zur Ärzte- und Patienten-Ansprache im Markt für verschreibungspflichtige Präparate. Heidelberg: Physica, 1992.

Umbach, Günter. Erfolgreich im Pharma-Marketing: Wie Sie im Produktmanagement von Arzneimitteln Ärzte, Apotheker, Patienten, Experten und Manager als Kunden gewinnen. Wiesbaden: Springer Fachmedien, 2011.

Holdford, David A. Marketing for pharmacists. 2^a ed. Washington, DC: American Pharmacists Association, 2007.

1945-, Lowe Robin y Cattee Peter, eds. Marketing and retail pharmacy. Abingdon, Oxon, UK: Radcliffe Medical Press, 1997.

Chisholm-Burns, Marie A. Pharmacy management, leadership, marketing, and finance. Sudbury, Mass: Jones and Bartlett Publishers, 2011.

Smith, Mickey C. Pharmaceutical marketing: Strategy and cases. New York: Pharmaceutical Products Press, 1991.

Stupp, Eric, Markus Schott y Alison Dennis. Distribution & marketing of drugs: Jurisdictional comparisons. London: Sweet & Maxwell, 2013.

Chisholm-Burns, Marie A., Allison M. Vaillancourt y Marv Shepherd. Pharmacy management, leadership, marketing, and finance. 2^a ed. Burlington, MA: Jones & Bartlett Learning, 2014.

Pines, Wayne L. Marketing compliance guide for drug and device manufacturers. Washington, DC: Thompson Pub. Group, 2008.

Guide to EU pharmaceutical regulatory law. Alphen aan den Rijn, The Netherlands: Kluwer Law International, 2010.

University), Stephen Wilson Pharmacy Seminar (30th 1984 Wayne State. The impact on pharmacy practice of the switch of legend drugs to OTC status: The 30th Annual Stephen Wilson Pharmacy Seminar proceedings : Tuesday, February 7, 1984, Wayne State University, Detroit, Michigan. Detroit, Mich: The University, 1985.

Meng, Werner. Marketing authorization for pharmaceutical products and the protection of submitted data. Baden-Baden: Nomos, 2000.

Clark, Michael E. Pharmaceutical and medical device law: Regulation of research, development, and marketing. Arlington, VA: Bloomberg BNA, 2015.

Hogshire, Jim. Pills-a-go-go: A fiendish investigation into pill marketing, art, history and consumption. Venice, Calif: Feral House, 1999.

2002), Marburger Gespräche zum Pharmarecht (5th. Vertriebswege für Arzneimittel in Europa: 5. Symposion von Wissenschaft und Praxis. Frankfurt am Main: PMI Verlag, 2003.

2002), Marburger Gespräche zum Pharmarecht (5th. Vertriebswege für Arzneimittel in Europa: 5. Symposion von Wissenschaft und Praxis. Frankfurt am Main: PMI Verlag, 2003.

Cotnoir, Michel. La mise en marché du médicament en droit pharmaceutique canadien. Montréal: Éditions Thémis, 1995.

Forschung erfolgreich vermarkten: Ein Ratgeber für die Praxis. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003.

Investigations, United States Congress House Committee on Commerce Subcommittee on Oversight and. Enforcing the laws on Internet pharmaceutical sales: Where are the Feds? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, May 25, 2000. Washington: U.S. G.P.O., 2000.

Hiromi, Okabe y Mathieu Mark P, eds. Global biotechnology product registration: E.U., U.S., and Japan. Waltham, MA: Parexel International Corp., 1997.

Barbara, Steinhoff y Blasius Helga, eds. Herbal medicinal products: Scientific and regulatory basis for development, quality assurance and marketing authorisation. Suttgart: Medpharm Scientific Publishers, 2003.

Wellcome Institute for the History of Medicine. Pills and profits: The selling of medicines since 1870 : an exhibition at the Wellcome Institute for the History of Medicine, 29 April to 19 August 1994. [London]: Wellcome Trust, 1994.

United States. Congress. Senate. A bill to amend title XVIII of the Social Security Act to require prompt payment to pharmacies under part D, to restrict pharmacy co-branding on prescription drug cards issued under such part, and to provide guidelines for Medication Therapy Management Services programs offered by prescription drug plans and MA-PD plans under such part. Washington, D.C: U.S. G.P.O., 2006.

Senate, United States Congress. A bill to amend title XVIII of the Social Security Act to require prompt payment to pharmacies under part D, to restrict pharmacy co-branding on prescription drug cards issued under such part, and to provide guidelines for Medication Therapy Management Services programs offered by prescription drug plans and MA-PD plans under such part. Washington, D.C: U.S. G.P.O., 2007.

1963-, Cassels Alan, ed. Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients. New York, NY: Nation Books, 2005.

Moynihan, Ray. Medicamentos que nos enferman: E industrias farmacéuticas que nos convierten en pacientes. Barcelona: Terapias Verdes, 2006.

Pharma 2005: Marketing to the individual. [S.l.]: PriceWaterhouseCoopers, 1999.

Law, Jacky. Big Pharma. Constable and Robinson, 2006.

Raffée, Erwin Dichtl Hans. Innovatives Pharma-Marketing: Marktorientierung als Erfolgsstrategie der 90ER Jahre. Gabler Verlag, 1989.

Big Pharma: Exposing the Global Healthcare Agenda. Carroll & Graf, 2006.

The antidote: Inside the world of new pharma. Simon & Schuster, 2014.

Werth, Barry. The Antidote: Inside the World of New Pharma. Simon & Schuster, 2014.

Umbach, Günter. Erfolgreich im Pharma-Marketing: Wie Sie Ärzte, Apotheker, Patienten, Experten und Manager als Kunden gewinnen. Springer Gabler, 2017.

Umbach, Günter. Erfolgreich im Pharma-Marketing: Wie Sie Ärzte, Apotheker, Patienten, Experten und Manager als Kunden gewinnen. Gabler Verlag, 2013.

Pharma-marketing: Gesundheitsökonomische Aspekte Einer Innovativen Industrie Am Beispiel Von Deutschland, Österreich Und Der Schweiz (Forum Marketing Und Management) (German Edition). De Gruyter Oldenbourg, 2008.

Goldman, Brian y Joel Lexchin. Doctors in Denial: How the Canadian Medical Profession Has Been Captured by Big Pharma. James Lorimer & Company Ltd., Publishers, 2017.

Urban, Thomas. Digitales Marketing in der Gesundheitsbranche : E-Health, Pharma 4. 0 und Gesundheits-Apps: Wie Sie B2B- und B2C-Zielgruppen Heute Erreichen. Springer Gabler. in Springer Fachmedien Wiesbaden GmbH, 2024.

Rx-To-OTC Switch - The Strategies Behind Switches.: The Strategies Behind Switches. The Results Today. Wiesbaden, Germany: Progress Publishing, 1997.

Marketing for Pharmacists. APhA Publications, 2003.

Marketing for Pharmacists. 2^a ed. American Pharmacists Association (APhA), 2007.

III, Benjamin F. Banahan. Marketing to Pharmacists. Haworth Press, 1999.

Pharmacy Management, Leadership, Marketing, and Finance. Jones & Bartlett Learning, LLC, 2012.

A, Chisholm-Burns Marie, Vaillancourt Allison M y Shepherd Marv, eds. Pharmacy management, leadership, marketing, and finance. Sudbury, Mass: Jones and Bartlett Publishers, 2011.